Nuclear Medicine: Page 82

SNMMI: Theranostic agent awarded Image of the Year
By Wayne Forrest
PHILADELPHIA - A PET image that shows the combined power of the diagnostic and therapeutic (theranostic) use of molecular imaging to identify and treat metastatic castration-resistant prostate cancer has been named this year's Image of the Year at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2018 06 26 22 57 6437 2018 06 26 Snmmi Image Of The Year 20180626220706
Live from SNMMI 2018: Nuclear medicine and patients
Patients justifiably are the centers of attention in imaging procedures, and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) is reaching out to them through the formation of a patient advocacy advisory board. In this video from SNMMI 2018, AuntMinnie.com Features Editor Wayne Forrest speaks with Josh Mailman, inaugural chair of the board.
June 26, 2018
2018 06 26 20 55 9981 Mailman Josh
SNMMI: Cerebrovascular risk tied to Alzheimer's disease
By Wayne Forrest
PHILADELPHIA - A study on amyloid plaque accumulation, white-matter hyperintensity, and cortical thickness has found that a patient's cerebrovascular characteristics should be considered for their potential effect on the progression of Alzheimer's disease. The findings were presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 26, 2018
2017 04 14 10 55 26 413 Brain General 400
SNMMI: Early prostate cancer therapy extends lives
By Erik L. Ridley
PHILADELPHIA - Providing lutetium-177 prostate-specific membrane antigen radioligand therapy earlier to patients with metastatic prostate cancer can extend lives, according to research presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 26, 2018
2018 06 25 22 13 1249 Lutetium 20180625221346
SNMMI: Fluciclovine-PET changes prostate treatment
By Wayne Forrest
PHILADELPHIA - With the addition of F-18 fluciclovine to PET/CT scans, clinicians changed the treatment regimen for a majority of men with recurrent prostate cancer and located previously undetected lesions in a new study, which was presented on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 25, 2018
2018 06 26 18 10 2725 2016 06 26 Fluciclovine Prostate Pet 400
FluoroPharma, Ground Fluor partner on MFBG agent
By AuntMinnie.com staff writers
Radiopharmaceutical developer FluoroPharma Medical has acquired an exclusive option to license the meta-fluorobenzylguanidine (MFBG) imaging agent from Ground Fluor Pharmaceuticals.
June 25, 2018
SNMMI: Molecular imaging method monitors gene therapy
By AuntMinnie.com staff writers
PHILADELPHIA - A new molecular imaging method can monitor the level and location of gene expression everywhere in the brain, enabling early assessment of gene therapy for brain disease, according to findings presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 25, 2018
2018 06 25 20 54 6996 Haywood Gambhir Figure 400
Live from SNMMI 2018: Nuclear medicine appropriate use
What's the best way to promote appropriate use of nuclear medicine? Dr. Sukhjeet Ahuja, director of evidence and quality at the Society of Nuclear Medicine and Molecular Imaging (SNMMI), spoke with Features Editor Wayne Forrest during this week’s SNMMI annual meeting about how appropriate use criteria are developed and how clinicians should proceed.
June 24, 2018
2018 06 25 21 53 9226 Ahuja Video
Live from SNMMI 2018: Securing the molybdenum supply
Global efforts are underway to ensure that adequate supplies of molybdenum-99 can match demand for nuclear medicine scans. Jim Harvey, PhD, of NorthStar Medical Radioisotopes spoke with Features Editor Wayne Forrest during this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting about the worldwide collaborative initiative.
June 24, 2018
2018 06 25 21 54 8005 Harvey Video 20180625211228
SNMMI: AI can predict survival in sarcoma patients
By Erik L. Ridley
PHILADELPHIA - Artificial intelligence (AI) algorithms can help predict disease-free survival in patients with soft-tissue sarcoma, according to research presented on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
June 24, 2018
2016 09 22 14 54 51 601 Computer Head 400
GE releases new systems, software at SNMMI 2018
By AuntMinnie.com staff writers
GE Healthcare unveiled new molecular imaging systems and software at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 conference.
June 24, 2018
2018 06 25 19 46 5324 Ge Snmmi 20180625195345
SNMMI announces new officers for 2018-2019
By AuntMinnie.com staff writers
PHILADELPHIA - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has introduced its new slate of officers for 2018-2019.
June 24, 2018
2018 06 25 17 29 0561 Minoshima Satoshi 20180625175103
Previous Page
Page 82 of 445
Next Page